A Post marketing study to assess the safety and efficacy of Capixyl Lotion (5%) in patients with Male Pattern Hair Loss
Phase 4
Completed
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2013/10/004104
- Lead Sponsor
- Glenmark Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 44
Inclusion Criteria
1.Healthy volunteers suffering from MPHL (18-45 yrs).
2.For Male volunteers MPHL of grade II-IV (Norwood classification)
3.As per the Trichoscopy report, -Anisotrichosis >20%
4.Subjects must comply with the protocol.
Exclusion Criteria
1.Non pattern hair loss
2.Thyroid related conditions
3.Other possible pathologies contributing to hair loss
4.Patient on Ketoconazole /Topical minoxidil / Finasteride or any other hair growth therapy
5.Not able to comply to protocol
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Trichoscopy <br/ ><br>2. Photographic Assessment <br/ ><br>3. Patients Self Assessment <br/ ><br>4. Subject Observation on Cosmetic acceptability and Ease of application <br/ ><br>5. Patient complianceTimepoint: 1. Trichoscopy- Baseline and after 4 months. <br/ ><br>2. Photographic Assessment- Visit 1, Visit 2 and Visit 3 <br/ ><br>3. Patients Self Assessment- Visits 2 and 3
- Secondary Outcome Measures
Name Time Method ATimepoint: NA